Dani Stoltzfus

Head, Chemistry Divison at NeuBase Therapeutics - Pittsburgh, PA, US

Dani Stoltzfus's Contact Details
HQ
N/A
Location
Company
NeuBase Therapeutics
Dani Stoltzfus's Company Details
NeuBase Therapeutics logo, NeuBase Therapeutics contact details

NeuBase Therapeutics

Pittsburgh, PA, US • 50 - 99 Employees
Major Drugs

NeuBase is developing ultra precision genetic medicines targeting rare, monogenic diseases, for which there are no approved therapies, as well as more common genetic disorders, including cancers that are resistant to current therapeutic approaches. NeuBase's pipeline includes therapeutic candidates for the treatment of myotonic dystrophy type 1 (DM1), Huntington's disease (HD), and cancer-driving point mutations in KRAS G12V and G12D, which are involved in many tumor types and have historically been "undruggable."

Biotechnology Gene Silencing Antisense Oligonucleotide Therapies Rare Disease Genetic Disease Huntington's Disease Myotonic Dystrophy CNS Disease Huntington's Disease
Details about NeuBase Therapeutics
Frequently Asked Questions about Dani Stoltzfus
Dani Stoltzfus currently works for NeuBase Therapeutics, Inc..
Dani Stoltzfus's role at NeuBase Therapeutics, Inc. is Head, Chemistry Divison.
Dani Stoltzfus's email address is ***@neubasetherapeutics.com. To view Dani Stoltzfus's full email address, please signup to ConnectPlex.
Dani Stoltzfus works in the Pharmaceuticals industry.
Dani Stoltzfus's colleagues at NeuBase Therapeutics are Dietrich Stephan, Barry Badeau, Ramesh Batwal, Zachary Miller, Rohan Kumbhare, Jessica Jeffers, Lyuqin Chen and others.
Dani Stoltzfus's phone number is N/A
See more information about Dani Stoltzfus